These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3735136

  • 1. Effects of hydralazine on regional blood flow in conscious dogs.
    Chelly JE, Doursout MF, Begaud B, Tsao CC, Hartley CJ.
    J Pharmacol Exp Ther; 1986 Aug; 238(2):665-9. PubMed ID: 3735136
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandins participate in the renal vasodilation due to hydralazine in dogs.
    Panzenbeck M, Baez A, Kaley G.
    J Pharmacol Exp Ther; 1986 May; 237(2):525-8. PubMed ID: 3084759
    [Abstract] [Full Text] [Related]

  • 3. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG, Wang HH.
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract] [Full Text] [Related]

  • 4. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC, Zyvoloski MG, Gross GJ, Brooks HL.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [Abstract] [Full Text] [Related]

  • 5. Functional role of alpha-calcitonin gene-related peptide in the regulation of the cardiovascular system.
    Shen YT, Pittman TJ, Buie PS, Bolduc DL, Kane SA, Koblan KS, Gould RJ, Lynch JJ.
    J Pharmacol Exp Ther; 2001 Aug; 298(2):551-8. PubMed ID: 11454916
    [Abstract] [Full Text] [Related]

  • 6. Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction.
    Rubin LJ, Lazar JD.
    J Clin Invest; 1981 Jan; 67(1):193-200. PubMed ID: 7451649
    [Abstract] [Full Text] [Related]

  • 7. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
    Kawashima S, Liang CS.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
    [Abstract] [Full Text] [Related]

  • 8. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interaction of atenolol with the systemic and regional hemodynamic effects of hydralazine in conscious renal hypertensive rabbits.
    Bolt GR, Saxena PR.
    J Pharmacol Exp Ther; 1984 Jul; 230(1):205-13. PubMed ID: 6747826
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vasodilator action of KB-944, a new calcium antagonist.
    Morita T, Yoshino K, Kanazawa T, Ito K, Nose T.
    Arzneimittelforschung; 1982 Jul; 32(9):1037-42. PubMed ID: 6890822
    [Abstract] [Full Text] [Related]

  • 13. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
    Sybertz EJ, Watkins RW, Baum T, Pula K, Rivelli M.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):156-62. PubMed ID: 3917504
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs.
    Di Francesco GF, Baldoli E, Marchetti G, Glässer A.
    Arzneimittelforschung; 1986 Jan; 36(1):84-8. PubMed ID: 3954821
    [Abstract] [Full Text] [Related]

  • 16. Baroreflex sensitivity as a determinant of responses to hydralazine in dogs.
    Vidrio H.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):247-51. PubMed ID: 6848745
    [Abstract] [Full Text] [Related]

  • 17. Regional blood flow changes in response to mildly pressor doses of triglycyl desamino lysine and arginine vasopressin in the conscious dog.
    Moursi MM, van Wylen DG, D'Alecy LG.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):360-8. PubMed ID: 3968637
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase blockade limits blood flow to collateral-dependent myocardium during exercise.
    Altman JD, Klassen CL, Bache RJ.
    Cardiovasc Res; 1995 Nov; 30(5):697-704. PubMed ID: 8595615
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.